Military Health System Research Program Notice of Funding Opportunity
ID: 353732Type: Posted
Overview

Buyer

Dept. of the Army -- USAMRAA (DOD-AMRAA)

Eligible Applicants

Unrestricted

Funding Category

Science and Technology and other Research and Development

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes
Timeline
    Description

    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), has announced a Notice of Funding Opportunity for the Military Health System Research Program (MHSRP), aimed at enhancing healthcare delivery for military and civilian populations. This program invites unrestricted applications focused on priority research areas such as economics, quality, health outcomes, and readiness, with the goal of fostering innovative research that supports the Military Health System as a learning health system. The total funding available for FY24 is estimated at $10 million, with key deadlines including a Letter of Intent due by June 10, 2024, and final applications due by September 20, 2024. Interested applicants can reach out to the DHA MHSR Program Mailbox at dha.ncr.j-9.mbx.hsr@health.mil for further information.

    Files
    Title
    Posted
    The Department of Defense (DoD) has issued a Notice of Funding Opportunity for the Military Health System Research Program (MHSRP) to support research that enhances healthcare delivery for the military and civilian populations. The program encourages applications from a diverse range of eligible entities, with a focus on addressing specified MHS priority topics, including economics, quality, health outcomes, and readiness. Key submission dates include the Letter of Intent (LOI) due by June 10, 2024, and the final application due by September 20, 2024. Eligible applicants can submit up to two LOIs but will only be awarded one. The funding amount for FY24 is expected to total $10 million. Proposals must align with both the MHSR priority topic areas and one of the clinical priority areas, which cover a range of health topics from cardiovascular and women's health to surgical care and telehealth. All applications will undergo scientific and programmatic reviews to assess their technical merit and relevance to the MHS. Successful proposals will lead to grants or cooperative agreements, emphasizing collaboration across various institutions while focusing on improving patient care outcomes and optimizing healthcare systems.
    Similar Opportunities
    Airman Readiness Medical Research (ARMR) Hybrid BAA
    Air Force -- Research Lab
    The Air Force Research Laboratory (AFRL) is soliciting proposals for the Airman Readiness Medical Research (ARMR) program through a Hybrid Broad Agency Announcement (BAA) designated FA8650-20-S-6008. The primary objectives of this initiative are to conduct medical research aimed at optimizing the health and performance of Airmen, focusing on ensuring medical availability and understanding the effects of various operational environments on Airman well-being. This program is critical for enhancing the operational readiness of military personnel, particularly in high-demand mission scenarios, with key research areas including aeromedical evacuation, cognitive performance, and exposure health. The total funding available for this program is estimated at $480 million, with individual awards ranging from $50,000 to $49 million. Interested parties are encouraged to submit white papers by May 1, 2025, and can direct inquiries to Amber A. Taylor at amber.taylor.9@us.af.mil.
    BROAD AGENCY ANNOUNCEMENT (BAA) for Extramural Biomedical and Human Performance Research and Development Department of Defense
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research Acquisition Activity (USAMRAA), has announced a Broad Agency Announcement (BAA) for Extramural Biomedical and Human Performance Research and Development. This opportunity invites unrestricted applicants to submit proposals aimed at advancing biomedical research and development, with a focus on enhancing human performance. The program is critical for fostering innovation in science and technology, particularly in areas that support the Department of Defense's mission. The estimated total program funding is $10 million, with individual awards ranging from $750,000 to $50 million, and proposals are due by July 31, 2028. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or by phone at 301-682-5507.
    Department of Defense HIV/AIDS Prevention Program
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering a federal grant opportunity titled the Department of Defense HIV/AIDS Prevention Program (DHAPP). This program aims to save lives and prevent HIV infections by supporting the development of interventions and programs within military health systems, particularly in foreign countries, to achieve HIV/AIDS epidemic control. The DHAPP focuses on enhancing military capacity for ownership and behavioral change, aligning with national strategies, and ensuring sustainable HIV prevention and treatment services. Interested applicants can reach out to Ebony Simmons at ebony.s.simmons.civ@health.mil or by phone at 301-619-2105 for further information. The application deadline is September 18, 2027, with an expected seven awards to be made under this cooperative agreement, which does not require cost sharing or matching.
    Research Coordinating Center
    Health Resources and Services Administration
    The Health Resources and Services Administration (HRSA) is forecasting a federal grant opportunity for the establishment of a Research Coordinating Center aimed at enhancing collaboration and providing technical assistance to Maternal and Child Health Bureau (MCHB)-funded research programs. The center will facilitate a continuous learning community, implement cross-site evaluations, and develop tools to translate research findings into practical applications. This initiative is critical for improving health outcomes and ensuring effective use of research in practice. The estimated total program funding is $501,000, with one award expected, and interested applicants can reach out to Jessica DiBari and Maura Maloney at (301) 443-2170 or via email at MCHBCC@hrsa.gov. The synopsis is anticipated to be posted on December 18, 2024, with applications closing on March 18, 2025, and project commencement expected on September 1, 2025.
    Staff Research Program
    Dept of the Army -- Materiel Command
    The Department of the Army's Materiel Command is offering a funding opportunity through the Staff Research Program, aimed at fostering collaborative basic research between its scientific staff and institutions of higher education. The program seeks to enhance the professional competence of Army Research Office (ARO) scientists by engaging in hands-on research that advances knowledge in various scientific disciplines, including engineering, physical, life, and information sciences. This initiative is crucial for maintaining the integrity of ARO's mission while promoting innovative research aligned with Army interests. Interested applicants must submit proposals via Grants.gov by February 19, 2025, with no cost-sharing requirement, and can direct inquiries to William A. Creech at william.a.creech3.civ@mail.mil or by phone at 919-549-4387.
    Health Science Futures: Office-Wide Innovative Solutions Opening for Advanced Research Projects Agency for Health
    Advanced Research Projects Agency for Health
    The Advanced Research Projects Agency for Health (ARPA-H) is inviting proposals for the "Health Science Futures: Office-Wide Innovative Solutions Opening for Advanced Research Projects Agency for Health" federal grant. This opportunity aims to support groundbreaking research projects that develop innovative technologies, tools, and platforms to address significant healthcare challenges and improve health outcomes across a wide range of diseases. Eligible applicants, specifically small businesses, are encouraged to submit solution summaries and proposals that align with the ARPA-H mission, focusing on transformative technologies, tools, and adaptable systems that can lead to revolutionary advances in medicine and healthcare. The grant does not require cost-sharing or matching, with an expected 100 awards available, and proposals are due by March 14, 2025. For further inquiries, interested parties can contact Mark Baxter at mark.baxter@arpa-h.gov or by phone at 301-827-4852.
    AHRQ Health Services Research Projects (R01)
    Agency for Health Care Research and Quality
    The Agency for Healthcare Research and Quality (AHRQ) is offering a funding opportunity titled "AHRQ Health Services Research Projects (R01)" aimed at advancing health services research aligned with its priorities. This initiative seeks applications that focus on improving healthcare quality, patient safety, and healthcare delivery across various settings, including hospitals and long-term care facilities. The funding is critical for facilitating impactful research that enhances the quality and equity of healthcare services in the United States, with a budget cap of $400,000 annually per project for a maximum duration of five years. Interested applicants must submit their proposals by June 5, 2024, and can direct inquiries to GrantQueries@ahrq.hhs.gov for further information.
    Maternal and Child Health (MCH) Research Consortium
    Health Resources and Services Administration
    The Health Resources and Services Administration (HRSA) is forecasting a grant opportunity titled the Maternal and Child Health (MCH) Research Consortium, aimed at establishing a consortium of research institutions to address evidence gaps in pregnancy, postpartum, and childhood populations. The initiative seeks to align research efforts with specific priorities identified within the MCH research field, focusing on maternal and child health and services for children with special health care needs. This cooperative agreement will provide an estimated total program funding of $1,800,000, with three awards expected to be made, and applications are open to eligible private institutions of higher education, public or non-profit institutions, and faith-based organizations. Interested applicants should note that the synopsis is expected to be posted on December 9, 2024, with a closing date for applications on March 10, 2025, and can reach out to Jessica DiBari or Maura Maloney at (301) 443-2170 or via email at MCHRC@hrsa.gov for further inquiries.
    Department of Defense Research and Education Program for Historically Black Colleges and Universities and Minority-Serving Institutions (HBCU/MI)
    Dept of the Army -- Materiel Command
    The Department of the Army's Materiel Command is offering a federal grant opportunity through the Department of Defense Research and Education Program aimed at Historically Black Colleges and Universities and Minority-Serving Institutions (HBCUs/MIs). This initiative seeks to enhance defense-related research and educational capabilities at these institutions, with a focus on increasing the number of graduates in STEM disciplines and fostering collaborations with other educational institutions and defense organizations. The program is critical for addressing national defense research priorities and strengthening the defense workforce through educational enhancements. Eligible applicants can apply for grants ranging from $100 million, with applications due by July 31, 2029. For further inquiries, interested parties can contact William A. Creech at william.a.creech3.civ@army.mil or by phone at 919-549-4387.
    NFRP Outreach and Invitation for Response
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research Acquisition Activity (USAMRAA), is forecasting an opportunity for a Research-based Other Transactions Agreement (rOTA) under the Neurofibromatosis Research Program (NFRP). This initiative aims to accelerate the clinical translation of basic research related to neurofibromatosis (NF) by conducting collaborative Phase I and II clinical trials focused on promising therapeutic agents for NF1, NF2, and schwannomatosis. Historically, this requirement has been addressed through assistance agreements, and the government is now seeking feedback on this proposed approach, emphasizing the need for cost-sharing arrangements and access to patient populations. Interested parties can direct inquiries to Jason D. Kuhns at jason.d.kuhns.civ@mail.mil, with the opportunity being part of the FY21 portfolio and requiring a demonstrated history of collaborative research among participants.